KAYLA PRICE: Open Payments
NPI 1124793377 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 13 payments from 10 companies in 2025. Trend: 2023 $639 · 2024 $793 · 2025 $231
Food & beverage: $231
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Lilly USA, LLC | 2 | $36 |
| Eisai Inc. | 1 | $22 |
| Organogenesis Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Kerendia, Leqembi, JARDIANCE, AFFINITY, TRELEGY ELLIPTA, Auvelity, Rybelsus, Cologuard Collection Kit.
Industry payments across GA — which companies pay providers there.
